PMC:7074424 / 21846-22131
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 474 | 63-83 | Gene | denotes | nucleocapsid protein | Gene:918763 |
| 492 | 47-51 | Chemical | denotes | PJ34 | MESH:C434926 |
| 493 | 124-126 | Chemical | denotes | H3 | MESH:C012616 |
| 494 | 128-190 | Chemical | denotes | 6-chloro-7-(2-morpholin-4-yl-ethylamino) quinoxaline-5,8-dione |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32201449-24564608-47217107 | 6-8 | 24564608 | denotes | 26 |
| 32201449-24564608-47217108 | 226-228 | 24564608 | denotes | 26 |
| 32201449-26542199-47217109 | 226-230 | 26542199 | denotes | 2669 |
| T31768 | 6-8 | 24564608 | denotes | 26 |
| T96844 | 226-228 | 24564608 | denotes | 26 |
| T90388 | 226-230 | 26542199 | denotes | 2669 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T648 | 63-83 | PG_4 | denotes | nucleocapsid protein |
| T647 | 93-102 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
| T646 | 142-151 | CHEBI:34856;CHEBI:34856 | denotes | morpholin |
| T645 | 151-157 | CHEBI:53233;CHEBI:53233 | denotes | -4-yl- |
| T644 | 157-167 | CHEBI:27750;CHEBI:27750 | denotes | ethylamino |
| T643 | 167-168 | CHEBI:53233;CHEBI:53233 | denotes | ) |
| T642 | 169-180 | CHEBI:36616;CHEBI:36616 | denotes | quinoxaline |
| T641 | 180-190 | CHEBI:53233;CHEBI:53233 | denotes | -5,8-dione |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T237 | 76-83 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T238 | 124-126 | Body_part | denotes | H3 | http://purl.org/sig/ont/fma/fma84131 |
| T239 | 213-216 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T240 | 273-276 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T118 | 56-59 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
| T120 | 266-269 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T255 | 76-83 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T256 | 93-102 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T257 | 130-136 | Chemical | denotes | chloro | http://purl.obolibrary.org/obo/CHEBI_47853 |
| T258 | 169-180 | Chemical | denotes | quinoxaline | http://purl.obolibrary.org/obo/CHEBI_36616 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T59 | 204-224 | http://purl.obolibrary.org/obo/GO_1905215 | denotes | inhibits RNA binding |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T128 | 0-285 | Sentence | denotes | 4KXJ.[26] On the basis of interactions between PJ34 and NTD of nucleocapsid protein, another inhibitor was designed that is H3 (6-chloro-7-(2-morpholin-4-yl-ethylamino) quinoxaline-5,8-dione), which also inhibits RNA binding.[2669] This highlights the importance of NTD in RNA binding. |